The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
They set up formularies, or lists of covered drugs, and negotiate rebates off the drug prices. The FTC said the rebating ...
The Dodge County Sheriff’s Office sent an undercover law enforcement officer, posing as the victim, to complete the transfer ...
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...
And lest the wanna-be bullies of public relations (like those called out in a 2021 Mother Jones’ barnburner Amazon exposé) ...
LinkedIn suspends AI training with UK user data after ICO intervention. Tech giants face scrutiny over data privacy in AI ...
When you’re hunting for work, a text alerting you to a new listing that sounds like your dream job could be your big break.
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the ...
The FTC is sounding the alarm on social media companies over how they utilize users' data and children's personal information ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
A new Federal Trade Commission staff report says major social media and video streaming services conducted vast surveillance ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback